P3 Health Partners (NASDAQ:PIII) Given Neutral Rating at BTIG Research

P3 Health Partners (NASDAQ:PIII)‘s stock had its “neutral” rating restated by BTIG Research in a report released on Friday,Benzinga reports.

Several other research firms also recently issued reports on PIII. Weiss Ratings reaffirmed a “sell (e+)” rating on shares of P3 Health Partners in a research note on Wednesday, October 8th. Lake Street Capital lowered their target price on P3 Health Partners from $20.00 to $12.50 and set a “buy” rating for the company in a research note on Monday, November 17th. One investment analyst has rated the stock with a Buy rating, one has given a Hold rating and one has assigned a Sell rating to the company. According to MarketBeat.com, the stock has an average rating of “Hold” and a consensus price target of $12.50.

P3 Health Partners Stock Performance

P3 Health Partners stock opened at $5.11 on Friday. The firm has a market capitalization of $36.84 million, a PE ratio of -0.13 and a beta of 0.87. P3 Health Partners has a one year low of $4.97 and a one year high of $14.50. The stock’s 50 day moving average price is $7.32 and its 200 day moving average price is $7.31. The company has a debt-to-equity ratio of 2.29, a quick ratio of 0.32 and a current ratio of 0.32.

P3 Health Partners (NASDAQ:PIII) last issued its quarterly earnings data on Thursday, November 13th. The company reported ($9.67) earnings per share (EPS) for the quarter, missing the consensus estimate of ($8.70) by ($0.97). P3 Health Partners had a negative net margin of 9.07% and a negative return on equity of 302.33%. The firm had revenue of $345.25 million during the quarter, compared to analyst estimates of $346.64 million. As a group, sell-side analysts expect that P3 Health Partners will post -0.67 EPS for the current fiscal year.

Institutional Trading of P3 Health Partners

An institutional investor recently raised its position in P3 Health Partners stock. Trinity Financial Advisors LLC grew its position in shares of P3 Health Partners Inc. (NASDAQ:PIII) by 22.5% during the first quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The fund owned 1,278,037 shares of the company’s stock after buying an additional 234,500 shares during the period. Trinity Financial Advisors LLC owned about 17.80% of P3 Health Partners worth $222,000 as of its most recent SEC filing. Institutional investors and hedge funds own 7.75% of the company’s stock.

About P3 Health Partners

P3 Health Partners Inc, a patient-centered and physician-led population health management company, provides superior care services in the United States. It operates clinics and wellness centers. P3 Health Partners Inc was founded in 2020 and is based in Henderson, Nevada.